Composition
- Active ingredients
- DOXYLAMINE SUCCINATE 10MG; PYRIDOXINE HYDROCHLORIDE 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA010598.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Bendectin
- Active substance
- doxylamine succinate
- Drug class
- Aminoalkyl ethers
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 30 Jul 1956
- Application
- NDA010598-002
- RxCUI
- 23665